Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-04-001997
Filing Date
2004-08-20
Accepted
2004-08-20 14:26:42
Documents
1
Group Members
ORBIMED ADVISORS LLCORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G (RULE 13D-1(B)) sc13g_081004-advisors.txt SC 13G 11896
  Complete submission text file 0000947871-04-001997.txt   13977
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-37954 | Film No.: 04988600
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 41 MADISON AVE 40TH FL NEW YORK NY 10010 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE